Valuation: IRIDEX Corporation

Market Cap 1.43Cr 1.28Cr 1.18Cr 1.07Cr 2.02Cr 135.66Cr 2.05Cr 14Cr 5.57Cr 71Cr 5.37Cr 5.26Cr 226.66Cr P/E 2026 *
-6.79x
P/E 2027 * -
Enterprise Value 1.43Cr 1.28Cr 1.18Cr 1.07Cr 2.02Cr 135.66Cr 2.05Cr 14Cr 5.57Cr 71Cr 5.37Cr 5.26Cr 226.66Cr EV / Sales 2026 *
0.27x
EV / Sales 2027 * 0.26x
Free-Float
60.42%
Yield 2026 *
-
Yield 2027 * -
1 day-1.42%
1 week-14.96%
Current month+25.40%
1 month+22.86%
3 months-14.65%
6 months-24.76%
Current year-30.70%
1 week 0.77
Extreme 0.76995
0.95
1 month 0.62
Extreme 0.615
1.02
Current year 0.61
Extreme 0.607
1.65
1 year 0.61
Extreme 0.607
1.65
3 years 0.61
Extreme 0.607
3.65
5 years 0.61
Extreme 0.607
9.46
10 years 0.61
Extreme 0.607
16.39
Manager TitleAgeSince
Chief Executive Officer 54 01/10/2024
Director of Finance/CFO 68 18/12/2018
Investor Relations Contact - -
Director TitleAgeSince
Chairman 60 24/06/2020
Director/Board Member 54 01/09/2018
Director/Board Member 66 17/03/2022
Date Insider Type Main position Quantity % Market Cap. Importance
01/10/26 Tax

Chief Executive Officer

-23,917 0.1362%
16/09/26 Buy

Chief Financial Officer

7,900 0.0450%
14/09/26 Buy

Chief Financial Officer

2,354 0.0134%
Change 5-day change 1-year change 3-year change Capi.($)
-3.02%-14.96%-25.47%-74.06% 1.43Cr
-1.32%+2.79%+25.16%+44.93% 26TCr
-1.63%+1.85%+8.11%+8.68% 16TCr
+1.48%+1.27%-5.54%+58.38% 15TCr
+1.18%+2.49%-55.31%-11.12% 6.43TCr
-1.01%+3.53%-15.17%-10.86% 5.19TCr
+2.04%+6.88%+10.60%+56.41% 5.03TCr
+0.90%+1.39%+16.34%+26.80% 4.99TCr
-1.24%-0.37%+19.37%+55.88% 4.88TCr
-0.63%+0.43%+26.45%+71.98% 4.29TCr
Average -0.24%+1.96%+0.45%+22.70% 8.75TCr
Weighted average by Cap. -0.39%+3.42%+6.83%+34.70%

Financials

2026 *2027 *
Net sales 5.25Cr 4.68Cr 4.34Cr 3.94Cr 7.4Cr 497.95Cr 7.52Cr 52Cr 20Cr 260.26Cr 20Cr 19Cr 831.97Cr 5.6Cr 4.99Cr 4.62Cr 4.2Cr 7.89Cr 530.72Cr 8.02Cr 55Cr 22Cr 277.38Cr 21Cr 21Cr 886.72Cr
Net income -20.86L -18.59L -17.22L -15.66L -29.39L -20Cr -29.87L -2.07Cr -81.24L -10Cr -78.26L -76.63L -33Cr 1T 891.4 825.74 750.79 1.41T 94.81T 1.43T 9.9T 3.89T 49.55T 3.75T 3.67T 2L
Net Debt - -
Projected Income Statement - Annual - IRIDEX Corporation
Logo IRIDEX Corporation
IRIDEX Corporation is an ophthalmic medical technology company. The Company is developing, manufacturing, and marketing versatile laser-based medical systems, delivery devices and consumable instrumentation. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probe products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.
Employees
93
Date Price Change Volume
19/26/19 $0.7900 -3.02% 36,164
16/26/16 $0.8146 -1.19% 42,345
15/26/15 $0.8245 +0.04% 1,64,994
14/26/14 $0.8241 -2.85% 34,069
13/26/13 $0.8483 -8.69% 1,85,464
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.8146USD
Average target price
2.750USD
Spread / Average Target
+237.59%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - IRIDEX Corporation
  1. Stock Market
  2. Stocks
  3. IRIX Stock